DrMandelNews.com General Health News

"Heart disease can be set off from just one high fat meal"

According to researchers just one high fat meal can set the stage for heart disease. Scientists have reported that just one high-fat milkshake can rapidly transform our healthy red blood cells into small, spiky cells which wreak havoc inside our blood vessels and help to set the perfect stage for heart disease.>>>Read more from Jagwire News, Augusta University>>> 

"Watching too much TV can be deadly"

Watching too much TV could turn out to be  deadly due to the consequences of spending too much time sitting around. The  American Heart Association  has reported there may be an  increased risk for a blood clot in a vein with an increase in time spent  watching TV.

"Study shows allowing kids to sip and taste alcohol is risky"

According to a study from the University of Buffalo parents who let their young kids occasionally sip and taste alcohol may be contributing to an increased risk for alcohol use and associated problems when those kids reach late adolescence.>>>Read more from University of Buffalo News Center>>> 

"A Japanese firm claims its drug kills the flu virus in a day"

The Japanese drugmaker Shionogi has claimed its influenza virus treatment baloxavir marboxil, which is not yet on the market, acts faster than any other flu drug which is available, with just a single dose of the medicine effectively killing the virus within a single day.>>>Read more from Science Altert>>> 

"Caution should be taken with candy imported to the USA"

Nearly everyone enjoys some candy now and  than. However, tooth decay, too many calories, and diabetes are not the only  risk factors associated with eating candy. The University of California San Fransisco has reported that in  California imported candy is at the top of the contaminated food list.

"Chloroquine and hydroxychloroquine may help fight cancer"

Two antimalarial drugs, chloroquine and  hydroxychloroquin, may help to fight cancer reports MedicalXpress. Researchers who are associated with the Repurposing  Drugs in Oncology (ReDO) project have said there has been enough evidence to  include these drugs in more clinical investigations. It appears these drugs make  tumor cells more sensitive to treatment for cancer.